[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Plagnat et al., 2002 - Google Patents

Elastase, α2‐macroglobulin and alkaline phosphatase in crevicular fluid from implants with and without periimplantitis

Plagnat et al., 2002

Document ID
9867609155458459409
Author
Plagnat D
Giannopoulou C
Carrel A
Bernard J
Mombelli A
Belser U
Publication year
Publication venue
Clinical oral implants research

External Links

Snippet

The aim of this investigation was to determine the presence of selected enzymes and enzyme inhibitors in crevicular fluid collected from implants with and without clinical, radiographic and microbiological signs of periimplantitis. Eleven implants with symptoms of …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes

Similar Documents

Publication Publication Date Title
Plagnat et al. Elastase, α2‐macroglobulin and alkaline phosphatase in crevicular fluid from implants with and without periimplantitis
Ataoglu et al. Interleukin‐1β, tumor necrosis factor‐α levels and neutrophil elastase activity in peri‐implant crevicular fluid: Correlation with clinical parameters and effect of smoking
Kinney et al. Oral fluid–based biomarkers of alveolar bone loss in periodontitis
Isaza‐Guzmán et al. Salivary levels of NLRP3 inflammasome‐related proteins as potential biomarkers of periodontal clinical status
Chang et al. Better oral hygiene is associated with lower risk of stroke
Silva et al. Characterization of progressive periodontal lesions in chronic periodontitis patients: levels of chemokines, cytokines, matrix metalloproteinase‐13, periodontal pathogens and inflammatory cells
Gupta et al. Role of salivary matrix metalloproteinase-8 (MMP-8) in chronic periodontitis diagnosis
Izadi Borujeni et al. Activated matrix metalloproteinase-8 in saliva as diagnostic test for periodontal disease? A case–control study
Kido et al. Calprotectin in gingival crevicular fluid correlates with clinical and biochemical markers of periodontal disease
Al‐Sabbagh et al. Bone remodeling‐associated salivary biomarker MIP‐1α distinguishes periodontal disease from health
Söder et al. Levels of matrix metalloproteinases‐8 and‐9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase‐9 and cholesterol in blood
Basegmez et al. Evaluation of periimplant crevicular fluid prostaglandin E2 and matrix metalloproteinase-8 levels from health to periimplant disease status: a prospective study
Lamster Evaluation of components of gingival crevicular fluid as diagnostic tests
Ramseier et al. Host‐derived biomarkers at teeth and implants in partially edentulous patients. A 10‐year retrospective study
Balli et al. Assessment of periostin levels in serum and gingival crevicular fluid of patients with periodontal disease
Alpagot et al. Risk factors for periodontitis in HIV+ patients
Sorsa et al. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic
Grigoriadou et al. Interleukin-1 as a genetic marker for periodontitis: review of the literature
Liskmann et al. Correlation of peri‐implant health and myeloperoxidase levels: a cross‐sectional clinical study
Sarlati et al. Receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in gingival crevicular fluid
Sophia et al. Comparative analysis of salivary alkaline phosphatase in post menopausal women with and without periodontitis
Airila‐Månsson et al. Influence of combinations of bacteria on the levels of prostaglandin E2, interleukin‐1β, and granulocyte elastase in gingival crevicular fluid and on the severity of periodontal disease
Sharma et al. Plasma and crevicular fluid osteopontin levels in periodontal health and disease
Ertugrul et al. Evaluation of beta‐2 microglobulin and alpha‐2 macroglobulin levels in patients with different periodontal diseases
Koss et al. Changes in saliva protein composition in patients with periodontal disease